Form 4: Surmodics Director Exits Equity Post-Merger

Susan E. Knight, a director of Surmodics Inc., no longer holds common stock or derivative securities following the company's merger into a wholly-owned subsidiary of BCE Parent, LLC.

Summary

• Surmodics, Inc. merged with BCE Merger Sub, Inc., resulting in Surmodics becoming a wholly-owned subsidiary of BCE Parent, LLC.
• Each outstanding share of Surmodics common stock was automatically cancelled and converted into the right to receive $43.00 per share in cash.
• Reporting person Susan E. Knight's restricted stock units (RSUs) vested immediately prior to the merger's effective time, entitling her to receive the $43.00 per share cash consideration.
• All unexercised employee stock options held by Ms. Knight were cancelled and converted into a cash payment equal to the product of the aggregate number of shares subject to the option and the excess, if any, of the $43.00 merger consideration over the option's exercise price.
• Following the merger, Ms. Knight no longer beneficially owns any common stock or derivative securities of Surmodics, Inc.

Sentiment

Score: 7

Explanation: The reporting person received a cash payout for their equity holdings, including in-the-money options, at a pre-determined merger price. While they no longer hold equity, the transaction provides liquidity and a defined return on their investment, which is generally a positive outcome for shareholders in an acquisition.

Positives

• The reporting person received a cash payout of $43.00 per share for all common stock and vested restricted stock units.
• The reporting person received a cash payout for in-the-money employee stock options, providing liquidity for those holdings.

Negatives

• The reporting person no longer holds any equity in Surmodics, Inc., thereby losing potential future upside from the company's performance.
• Employee stock options with an exercise price higher than the $43.00 merger consideration were cancelled without value.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4.

Industry Context

This filing reflects the standard outcome of a corporate merger where a publicly traded company is acquired and taken private. It indicates a completed consolidation event within the industry, leading to the conversion of public equity into cash for shareholders and equity holders.

Stakeholder Impact

• Shareholders: All common shareholders received $43.00 per share in cash, converting their equity into liquidity.
• Employees (with options/RSUs): Employees holding in-the-money options and RSUs received cash payouts, while out-of-the-money options were cancelled.

Key Dates

Keywords

Surmodics Inc, SRDX, Merger, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, BCE Parent LLC, Equity Conversion, Director Holdings